Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 5—May 2004

Research

Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients

Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*Comments to Author , and Pan-Chyr Yang*
Author affiliations: *National Taiwan University Hospital, Taipei, Taiwan

Main Article

Table 2

Initial laboratory data of 76 patients with SARSa

Laboratory parameters
(normal range) Mean ± standard deviation No. (%) of patients with abnormal data
Leukocyte counts (4–9 x 109/L)
6.0 ± 2.9

Leukopenia

15 (19.7)
  Lymphopeniab

49 (64.5)
  Platelet counts (150–450 X 109/L)
159.7±54.0

  Thrombocytopenia

35 (46.1)
AST (<35 U/L)
36.7±20.0
24c (35.3)
ALT (<35 U/L)
27.5±20.4
11d (23.9)
LDH (<460 U/L)
597.8±426.0
9e (56.3)
CK (<190 U/L)
216.5±444.3
17f (26.1)
CRP (<0.8 mg/dL) 3.9±3.6 53g (77.9)

aSARS, severe acute respiratory syndrome; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; CK, creatine kinase; CRP, C-reactive protein.
bDefined as <1 X 109/L.
cOnly 68 patients had been tested.
dOnly 46 patients had been tested.
eOnly 16 patients had been tested.
fOnly 65 patients had been tested.
gOnly 68 patients had been tested.

Main Article

TOP